ARID5B and acute lymphoblastic leukemia: More studies are needed to investigate the way risk alleles of ARID5B SNPs impact on MTX metabolism, and further examinations of ARID5B variation in the context of different ALL treatment regimens are warranted to refine its value as a prognostic marker.